Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
van Weelden G, Bobiński M, Okła K, van Weelden WJ, Romano A, Pijnenborg JMA. van Weelden G, et al. Among authors: pijnenborg jma. Mar Drugs. 2019 Jan 7;17(1):32. doi: 10.3390/md17010032. Mar Drugs. 2019. PMID: 30621045 Free PMC article. Review.
Poor outcome in hypoxic endometrial carcinoma is related to vascular density.
Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium; Massuger LFAG, Bussink J, Pijnenborg JMA. Reijnen C, et al. Among authors: pijnenborg jma. Br J Cancer. 2019 May;120(11):1037-1044. doi: 10.1038/s41416-019-0461-2. Epub 2019 Apr 23. Br J Cancer. 2019. PMID: 31011231 Free PMC article.
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review.
van Weelden WJ, Massuger LFAG; ENITEC; Pijnenborg JMA, Romano A. van Weelden WJ, et al. Among authors: pijnenborg jma. Front Oncol. 2019 May 7;9:359. doi: 10.3389/fonc.2019.00359. eCollection 2019. Front Oncol. 2019. PMID: 31134155 Free PMC article.
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.
van Weelden WJ, van der Putten LJM, Inda MA, van Brussel A, Snijders MPLM, Schriever LMM, Bulten J, Massuger LFAG, van de Stolpe A, Pijnenborg JMA. van Weelden WJ, et al. Among authors: pijnenborg jma. Br J Cancer. 2020 Sep;123(5):785-792. doi: 10.1038/s41416-020-0925-4. Epub 2020 Jun 8. Br J Cancer. 2020. PMID: 32507853 Free PMC article.
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.
van Weelden WJ, Reijnen C, Küsters-Vandevelde HVN, Bulten J, Bult P, Leung S, Visser NCM, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Huvila J, Koskas M, Weinberger V, Bednarikova M, Hausnerova J, Snijders MPLM, Matias-Guiu X, Amant F; ENITEC-Consortium. van Weelden WJ, et al. Hum Pathol. 2021 Mar;109:80-91. doi: 10.1016/j.humpath.2020.12.003. Epub 2020 Dec 15. Hum Pathol. 2021. PMID: 33338506
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW, van Weelden WJ, Visser NCM, Bulten J, van der Putten LJM, van de Vijver K, Santacana M, Colas E, Gil-Moreno A, Moiola CP, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Bednarikova M, Hausnerova J, van der Wurff AA, Matias-Guiu X, Amant F; ENITEC Consortium; Snijders MPLM, Küsters-Vandevelde HVN, Reijnen C, Pijnenborg JMA. Vrede SW, et al. Among authors: pijnenborg jma. Gynecol Oncol. 2021 Jun;161(3):787-794. doi: 10.1016/j.ygyno.2021.03.031. Epub 2021 Apr 12. Gynecol Oncol. 2021. PMID: 33858677 Free article.
174 results